Literature DB >> 22311706

The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.

Daniel P Dever1, Lisa A Opanashuk.   

Abstract

The aryl hydrocarbon receptor (AhR), a ligand-activated member of the basic helix-loop-helix (bHLH)/PER-ARNT-SIM (PAS) transcription superfamily, is known to regulate the toxicity of polyaromatic halogenated hydrocarbon environmental chemicals, most notably dioxin. However, the AhR has also been implicated in multiple stages of tumorigenesis. Medulloblastoma (MB), a primary cerebellar brain tumor arising in infants and children, is thought to originate from abnormally proliferating cerebellar granule neuron precursors (GNPs). GNPs express high levels of the AhR in the external germinal layer of the developing cerebellum. Moreover, our laboratory has previously reported that either abnormal activation or deletion of the AhR leads to dysregulation of GNP cell cycle activity and maturation. These observations led to the hypothesis that the AhR promotes the growth of MB. Therefore, this study evaluated whether the AhR serves a pro-proliferative role in an immortalized MB tumor cell line (DAOY). We produced a stable AhR knockdown DAOY cell line [AhR short hairpin RNA (shRNA)], which exhibited a 70% reduction in AhR protein levels. Compared with wild-type DAOY cells, AhR shRNA DAOY cells displayed an impaired G(1)-to-S cell cycle transition, decreased DNA synthesis, and reduced proliferation. Furthermore, these cell cycle perturbations were correlated with decreased levels of the pro-proliferative gene Hes1 and increased levels of the cell cycle inhibitor p27(kip1). Supplementation experiments with human AhR restored the proliferative activity in AhR shRNA DAOY cells. Taken together, our data show that the AhR promotes proliferation of MB cells, suggesting that this pathway should be considered as a potential therapeutic target for MB treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311706      PMCID: PMC3336804          DOI: 10.1124/mol.111.077305

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL.

Authors:  Toshihisa Hayashibara; Yasuaki Yamada; Naoki Mori; Hitomi Harasawa; Kazuyuki Sugahara; Takayuki Miyanishi; Shimeru Kamihira; Masao Tomonaga
Journal:  Biochem Biophys Res Commun       Date:  2003-01-03       Impact factor: 3.575

2.  Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast.

Authors:  G Elizondo; P Fernandez-Salguero; M S Sheikh; G Y Kim; A J Fornace; K S Lee; F J Gonzalez
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

3.  Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation.

Authors:  D J Solecki; X L Liu; T Tomoda; Y Fang; M E Hatten
Journal:  Neuron       Date:  2001-08-30       Impact factor: 17.173

4.  Overexpression of aryl hydrocarbon receptor in human lung carcinomas.

Authors:  Pinpin Lin; Han Chang; Wen-Tin Tsai; Meng-Hsiang Wu; Yung-Shen Liao; Jung-Ta Chen; Jang-Ming Su
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

5.  B cell differentiation and isotype switching is related to division cycle number.

Authors:  P D Hodgkin; J H Lee; A B Lyons
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

6.  Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer.

Authors:  Alexander Koliopanos; Jörg Kleeff; Yi Xiao; Stephen Safe; Arthur Zimmermann; Markus W Büchler; Helmut Friess
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

7.  A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors.

Authors:  Patrik Andersson; Jacqueline McGuire; Carlos Rubio; Katarina Gradin; Murray L Whitelaw; Sven Pettersson; Annika Hanberg; Lorenz Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-09       Impact factor: 11.205

8.  HES-1, a novel target gene for the aryl hydrocarbon receptor.

Authors:  Jane Sohn Thomsen; Silke Kietz; Anders Ström; Jan-Ake Gustafsson
Journal:  Mol Pharmacol       Date:  2004-01       Impact factor: 4.436

9.  Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

Authors:  Maen Abdelrahim; Roger Smith; Stephen Safe
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

Review 10.  Role of the aryl hydrocarbon receptor in cell cycle regulation.

Authors:  Alvaro Puga; Ying Xia; Cornelis Elferink
Journal:  Chem Biol Interact       Date:  2002-09-20       Impact factor: 5.192

View more
  24 in total

1.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

2.  Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.

Authors:  Naveen K Neradugomma; Michael Z Liao; Qingcheng Mao
Journal:  Mol Pharmacol       Date:  2016-12-14       Impact factor: 4.436

3.  Signaling network map of the aryl hydrocarbon receptor.

Authors:  Soujanya D Yelamanchi; Hitendra Singh Solanki; Aneesha Radhakrishnan; Lavanya Balakrishnan; Jayshree Advani; Remya Raja; Nandini A Sahasrabuddhe; Premendu Prakash Mathur; Pinaki Dutta; T S Keshava Prasad; Márta Korbonits; Aditi Chatterjee; Harsha Gowda; Kanchan Kumar Mukherjee
Journal:  J Cell Commun Signal       Date:  2016-07-27       Impact factor: 5.782

Review 4.  Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

Authors:  Stephen Safe; Syng-Ook Lee; Un-Ho Jin
Journal:  Toxicol Sci       Date:  2013-06-14       Impact factor: 4.849

5.  Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1.

Authors:  K Frauenstein; U Sydlik; J Tigges; M Majora; C Wiek; H Hanenberg; J Abel; C Esser; E Fritsche; J Krutmann; T Haarmann-Stemmann
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

6.  Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.

Authors:  Cindy Tran; Oliver Richmond; Latayia Aaron; Joann B Powell
Journal:  Biochem Pharmacol       Date:  2012-12-22       Impact factor: 5.858

7.  Aryl hydrocarbon receptor deletion in cerebellar granule neuron precursors impairs neurogenesis.

Authors:  Daniel P Dever; Zachariah O Adham; Bryan Thompson; Matthieu Genestine; Jonathan Cherry; John A Olschowka; Emanuel DiCicco-Bloom; Lisa A Opanashuk
Journal:  Dev Neurobiol       Date:  2015-08-17       Impact factor: 3.964

Review 8.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

9.  3-methylcholanthrene induces neurotoxicity in developing neurons derived from human CD34+Thy1+ stem cells by activation of aryl hydrocarbon receptor.

Authors:  Abhishek K Singh; Mahendra P Kashyap; Vivek Kumar; Vinay K Tripathi; Dharmendra K Yadav; Firoz Khan; Sadaf Jahan; Vinay K Khanna; Sanjay Yadav; Aditya B Pant
Journal:  Neuromolecular Med       Date:  2013-07-12       Impact factor: 3.843

10.  The aryl hydrocarbon receptor facilitates the human cytomegalovirus-mediated G1/S block to cell cycle progression.

Authors:  Pooya Naseri-Nosar; Maciej T Nogalski; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.